Aladesuyi Arogundade, Olubankole
Nguyen, Sandra
Leung, Ringo
Wainio, Danielle
Rodriguez, Maria
Ravits, John
Funding for this research was provided by:
Amyotrophic Lateral Sclerosis Association (5356S3)
Target ALS (20134792)
National Institute of Neurological Disorders and Stroke (NIH R01NS088578, NS047101, NS047101)
Pam Golden
Kraatz Family
Nicholas Martin Jr. Family Foundation
Division of Molecular and Cellular Biosciences (DGE-1650112)
Article History
Received: 13 January 2021
Accepted: 30 January 2021
First Online: 15 February 2021
Ethics approval and consent to participate
: Human tissue acquisition protocols followed HIPAA-compliant informed consent procedures and were approved by Institutional Review Boards and came from two sources, the University of California, San Diego (UCSD) ALS biorepository (Benaroya Research Institute, Seattle, WA IRB #10058 and UCSDIRB #20056) and the Target ALS biorepository (by material transfer agreement).
: Not applicable.
: The authors declare that they have no competing interests.